Our Timothy Bullock, PhD, and his team have discovered a defect in immune cells known as “killer T cells” that explains why they struggle to destroy cancer tumors. By fixing this defect, scientists could make the cells much better at killing cancer cells.
Here's a well-earned recognition: Our Daniel "Trey" Lee's pioneering work in battling pediatric leukemia has been honored as one of 2017’s top 10 Clinical Research Achievements by the Clinical Research Forum. Dr. Lee’s research weaponizes immune cells, known as T cells, in pediatric and young adult clinical trial participants to…
In the focused ultrasound trials I've told you about previously, the point has been to use the scalpel-free surgery to destroy tissue. Our latest trial -- for metastatic breast cancer -- puts an interesting twist on that. In this trial, the focused ultrasound isn't used in an attempt to burn…
